Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran

Background: Hip, vertebral and wrist fractures are the most common consequences of osteoporosis. This study aimed at analyzing the cost-effectiveness of teriparatide (CinnoPar®), compared with alendronate and risedronate, in the treatment of women aged 60 and over with postmenopausal osteoporosis in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Med J Islam Repub Iran
Autori principali: Ebadi Fard Azar, Amir Ali, Rezapour, Aziz, Alipour, Vahid, Sarabi-Asiabar, Ali, Gray, Serajaddin, Mobinizadeh, Mohammadreza, Yousefvand, Mani, Arabloo, Jalal
Natura: Artigo
Lingua:Inglês
Pubblicazione: Iran University of Medical Sciences 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5804430/
https://ncbi.nlm.nih.gov/pubmed/29445668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14196/mjiri.31.39
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi